Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2026 Jul 22;65(30):17325–17333. doi: 10.1021/acs.inorgchem.6c01698

Cobalt(III)–Schiff Base Coordination to Nsp1, a SARS-CoV‑2 Protein

Maryann Morales 1, Moon Young Yang 1, William A Goddard III 1,*, Harry B Gray 1,*, Jay R Winkler 1,*
PMCID: PMC13439656  PMID: 42483978

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suppresses host immune defenses through the activity of nonstructural protein 1 (Nsp1), which inhibits host mRNA translation by occluding the mRNA entry channel of the 40S ribosomal subunit. Here, we investigate whether Co­(III)­(acacen)­(NH3)2 + (acacen = bis­(acetylacetone)­ethylenediamine) can disrupt Nsp1 function through coordination to histidine residues. Using 59Co nuclear magnetic resonance (NMR) spectroscopy, we show that Co­(III)­(acacen)­(NH3)2 + undergoes axial ligand substitution upon interaction with an Nsp1-derived peptide encompassing the functionally critical His165 residue. Computational analysis supports a coordination structure in which an axial NH3 ligand is displaced by a histidine imidazole. Although proteolytic fragmentation followed by mass spectrometric analysis revealed multiple histidine binding sites in full-length Nsp1, assigned to His13, the His81/His83 region, and His165, in vitro translation assays confirmed that the addition of Co­(III)­(acacen)­(NH3)2 + did not restore host protein synthesis.


graphic file with name ic6c01698_0012.jpg


graphic file with name ic6c01698_0010.jpg

Introduction

A central factor contributing to the pathogenicity and persistence of SARS-CoV-2 is its capacity to evade and suppress host immune defenses through a variety of mechanisms. These include shielding viral replication intermediates, mimicking host molecular structures, disrupting antiviral signaling cascades, and weakening interferon responses.

One prominent mechanism is inhibition of protein synthesis, in which the virus impairs host mRNA translation. In the process of blocking the production of cellular proteins, SARS-CoV-2 both redirects the translational machinery toward viral RNA and suppresses the host’s ability to mount an antiviral response. A key component of this process is nonstructural protein 1 (Nsp1), a conserved coronavirus factor that inhibits host mRNA translation. ,

During SARS-CoV-2 infection, the overlapping open reading frame ORF1ab is translated from the positive-sense genomic RNA into a large polyprotein that undergoes autoproteolysis to create 16 nonstructural proteins (Nsps), the first of which is Nsp1. Nsp1 employs a multipronged strategy to suppress host protein synthesis, with inhibition of translation primarily attributable to its interaction with the 40S ribosomal subunit. ,, Upon binding, the intrinsically disordered C-terminal domain of Nsp1 adopts a helix-turn-helix conformation that occludes the mRNA entry channel, thereby blocking translation initiation and promoting degradation of host mRNAs. ,− This interaction is critically mediated by a short loop connecting the two helices, which contains residues Lys164 and His165. Structural and mutational studies have shown that Lys164 and His165 engage the 18S rRNA through stacking and backbone interactions, and disruption of these residues abolishes Nsp1-mediated translation inhibition, mRNA degradation, and suppression of type I interferon responses. , These findings underscore the functional importance of the Lys164-His165 region and highlight it as a key determinant of Nsp1 pathogenic activity.

Together, these interactions highlight the C-terminal domain of Nsp1 as a crucial regulator of the host response to coronavirus infection. Given its central role in protein synthesis inhibition, this region is an attractive therapeutic target: disrupting Nsp1–40S ribosome binding could restore host protein synthesis and immune signaling, therefore improving antiviral defense.

Investigators have computationally screened libraries of commercially available organic drugs in the search of candidates that might target Nsp1. While some hits have been identified, their binding affinities are insufficient to produce meaningful therapeutic effects. This has prompted exploration beyond traditional organic molecules toward metal-based complexes, which offer well-defined three-dimensional structures and access to novel modes of action not always available in organic compounds.

Medicine has advanced substantially over time, with therapeutic strategies evolving from an exclusive reliance on organic molecules to the incorporation of metal-based complexes. Cisplatin was first synthesized in 1845 by Michele Peyrone, but its biological activity was not recognized until 1965 through the work of Barnett Rosenberg. , This discovery revolutionized medicine by opening an entirely new field focused on the therapeutic properties of metal complexes. As a result, metal-containing reagents have emerged as a distinct class of drug candidates.

We have exploited the sensitivity of intrinsically disordered Nsp1 regions to metal-ion coordination. Transition metal ions can bind N-donor and O-donor side chains, altering protein conformation and function. In previous work we demonstrated that copper­(II) binds to the disordered C-terminal region of Nsp1 by His165 imidazole and backbone ligation, although the rapid ligand exchange properties of this complex disfavor therapeutic applications. , We think it likely that metal ions that form substitution-inert complexes will be better at selectively attacking viral proteins.

Cobalt­(III) Schiff-base complexes exhibit antiviral activity, and their interactions with both proteins and nucleic acids have been studied extensively. , In viral proteins, binding to the Co­(III) center often occurs by substitution of histidine imidazole for an axial ammine or other ligand. The robust Co­(III) coordination framework provides a highly tunable platform, allowing for precise control over both axial and equatorial ligation. ,

In this work, we investigated Co­(III)­(acacen)­(NH3)2 + interactions with Nsp1-CT10, a C-terminal 10 residue peptide (Figure ), since an imidazole can displace an ammine in an axial position of this complex. ,,, We employed 59Co NMR and other spectroscopic techniques along with quantum mechanics (QM) calculations to monitor changes in the Co­(III) coordination environment in reactions with Nsp1-CT10. In addition, we used proteolytic fragmentation of full-length Nsp1 coupled with mass spectrometry to identify histidine residues bound to Co­(III); and we evaluated the inhibitory capacity of Co­(III) using in vitro translation assays.

1.

1

Left: Drawing of Co­(III)­(acacen)­(NH3)2 +; Right: Nsp1-CT10 sequence (acetylated N-terminus).

Methods

Decapeptide

N-terminally acetylated decapeptide Ac-ENWNTKHSSG (Nsp1-CT10) was obtained from Genscript Biotech Corporation.

Full-Length Nsp1

The following procedure was adapted from previous literature.

Plasmids encoding the WT Nsp1 sequence were obtained from GenScript Biotech. The plasmid was transformed into E. coli BL21­(DE3) and cells were grown in 2xYT medium at 37 °C. When the cultures reached an optical density at 600 nm (OD600) of 0.8, IPTG was added to a final concentration of 0.5 mM and the temperature was lowered to 18 °C. Cells were harvested after 16 h by centrifugation (4000 rpm, 10 min, 4 °C). Pellets were resuspended in lysis buffer (50 mM HEPES-KOH pH 7.6, 500 mM KCl, 5 mM MgCl2, 10% (wt/vol) glycerol, 0.5 mM TCEP) and lysed using a sonicating tip (80% amplitude, 5 min, 3 s on, 17 s off). The lysed cells were stirred with DNase, RNase, and protease inhibitor for an hour before clearing by centrifugation (12,000 rpm, 30 min, 4 °C). The lysate was loaded onto a Ni-NTA resin column, then the protein was washed with the lysis buffer containing increasing concentrations of imidazole up to 40 mM. The His6-tagged protein was eluted with lysis buffer containing 300 mM imidazole (Im). The eluent was buffer-exchanged into lysis buffer to remove imidazole. The samples were incubated with TEV protease (NEB # P8112). The cleaved Nsp1 was isolated on a Ni-NTA resin column. The sample was buffer-exchanged into its storage buffer (40 mM HEPES-KOH pH 7.6, 200 mM KCl, 40 mM MgCl2, 10% (wt/vol) glycerol, 1 mM TCEP) and concentrated using an Amicon Ultra-15 centrifugal filter (3-kDA molecular weight cutoff (MWCO)), then flash frozen in liquid nitrogen and stored at −80 °C.

Synthetic Methods

Synthesis was based on a literature procedure (Scheme ). Co­(III)­(acacen)­(NH3)2 + is a known compound; characterization data reported in the SI are consistent with those in a previous report.

1. Scheme for Acacen and Co­(III)­(acacen)­(NH3)2 + Synthesis.

1

Ligand Synthesis

Ethylenediamine (2.71 g, 45.1 mmol) was dissolved in ethanol (50 mL). A solution of freshly distilled acetylacetone (9.21 mL, 90.2 mmol) in ethanol was added dropwise over 2 h with continuous stirring. The mixture was stirred for an additional 3 h, then filtered. The solid was washed with water (3 × 20 mL) and diethyl ether (3 × 20 mL) and dried under vacuum to afford product (acacen).

1H NMR (400 MHz, CDCl3) δ 10.90 (s, 2H), 4.99 (s, 2H), 3.49–3.36 (m, 4H), 2.00 (s, 6H), 1.91 (s, 6H).

[Co­(acacen)­(NH3)2]­Cl

After acacen (500 mg, 2.22 mmol) was dissolved in methanol (50 mL), cobalt­(II) chloride hexahydrate (541 mg, 2.27 mmol) was added under a nitrogen atmosphere, and the solution was heated to 60 °C with stirring for 30 min. Saturated ammonia in methanol (0.25 mL) was introduced, and the mixture was refluxed for 1 h. More (2.5 mL) saturated ammonia in methanol was added, after which oxygen was bubbled through the reaction mixture overnight. The solid product was collected by filtration, washed with cold methanol (3 × 10 mL) followed by diethyl ether (3 × 10 mL), and dried under vacuum.

1H NMR assignments are in the SI.

Spectroscopic Methods

59Co NMR Spectra

NMR spectra were recorded in D2O solutions. A Bruker Neo 400 with a broadband iProbe operating at 95.79 MHz was used to obtain 59Co NMR spectra. Standard parameters: 16,000 scans with a 10-microsecond pulse, 20 ms acquisition time, 100 ms relaxation delay, and a 100,000 Hz (1044 ppm) sweep width.

59Co NMR spectra were collected in D2O solutions to characterize the cobalt coordination environment before and after reaction with Nsp1-CT10. Nsp1-CT10 was added to a D2O solution of Co­(acacen)­(NH3)2Cl until a 1:1 reaction mixture was obtained, and solutions were incubated overnight at room temperature to allow for ligand exchange. The overnight equilibration period also ensured complete deuterium exchange at the axial ammine ligands that can otherwise contribute to spectral heterogeneity and line broadening in D2O. Spectra were acquired on 10 mM Co­(III):Nsp1-CT10 solutions.

The reference standard for 59 Co NMR spectra was Kc3[Co­(CN)6] (set to 0 ppm). The 59Co NMR spectrum of the standard (20 mM in D2O) is in the repository.

Mass Spectrometry

Sample Preparation

Purified protein samples were dissolved in 8 M urea (Sigma) buffered with 50 mM HEPES (pH 7.5). The samples were reduced using 5 mM tris­(2-carboxyethyl)­phosphine (TCEP, Thermo Fisher Scientific) and alkylated using 20 mM chloroacetamide (CAA, Sigma). The samples were diluted using 50 mM HEPES (pH 7.5) until the urea concentration was lower than 2 M, and CaCl2 (Sigma, 5 mM) was added. Trypsin was added to the sample with a 1:50 enzyme to substrate ratio according to protein quantitation, followed by digestion at 37 °C overnight (∼14 h).

After trypsinization, the digested peptides were eluted from the S-trap device according to the manufacturer’s protocol and dried using a speedvac. The samples were subsequently desalted again using Pierce C18 Spin Columns (Thermo Fisher Scientific, 89870) according to the manufacturer’s protocol and dried again. The dried samples were stored at −80° before LC-MS/MS analysis.

LC-MS/MS Analysis

Samples were resuspended in 0.1% formic acid (Thermo Fisher Scientific, 85178) solution, and peptide concentration was tested using the Pierce Quantitative Fluorometric Peptide Assay (Thermo Fisher Scientific, 23290). LC-MS/MS experiments were performed by loading a 500 μg sample onto a Thermo Vanquish Neo UHPLC system (Thermo Fisher Scientific) connected to an Orbitrap Eclipse Tribrid mass spectrometer (Thermo Fisher Scientific). Peptides were separated on an Aurora UHPLC Column (25 cm × 75 μm, 1.6 μm C18, AUR2–25075C18A, Ion Opticks) with a flow rate of 0.35 mL/min for 70 min. The gradient was composed of 2–6% solvent B for 3.5 min, 6 to 25% B for 41.5 min, 25 to 40% B for 15 min, 40 to 98% B for 2 min, 98% B for 5 min, and 98 to 2% B for 3 min. Solvent A was 97.8% H2O, 2% acetonitrile, and 0.2% formic acid, and solvent B was 19.8% H2O, 80% acetonitrile, and 0.2% formic acid. MS1 scans were acquired in the range 375 to 1600 m/z in the Orbitrap at 120 k resolution. The maximum injection time was 50 ms, and the automatic gain control target was 250%. MS2 scans were acquired using quadrupole isolation mode and higher-energy collisional dissociation activation type in the ion-trap. The isolation window was 1.2 m/z, collision energy was 30 NCE, the automatic gain control was set at 100%, and maximum injection time was set as dynamic. Other global settings were set to the following: ion source type, NSI; spray voltage, 1800 V; ion transfer tube temperature, 300 °C. Method modification and data collection were performed using Xcalibur software (Thermo Fisher Scientific).

Data Analysis for Proteomics

Proteomic analysis was performed using Proteome Discoverer 3.1 (PD 3.1, Thermo Fisher Scientific) software, the Nsp1 protein sequence, and SequestHT with Percolator validation. Percolator false discovery rates were set at 0.001 (strict) and 0.01 (relaxed). Peptide false discovery rates were set at 0.001 (strict) and 0.01 (relaxed), with medium confidence and a minimum peptide length of 6. Carbamidomethyl (C) was set as a static modification; oxidation (M) and Co­(III) complex (H, + 296.0809 Da) were set as dynamic modification; acetyl (protein N-term), Met-loss (Protein N-term M), and Met-loss + acetyl (Protein N-term M) set as dynamic N-terminal modifications. Protein abundance normalization was performed relative to total peptide. Differential expression analysis was performed using an in-house python script.

Computational Methods

All quantum chemical (QM) NMR calculations were performed using Gaussian16. To investigate the coordination environment of Co­(III)­(acacen) complexes upon peptide binding, a series of plausible axial ligand substitution models were constructed, including retention of both axial ammonia ligands, substitution of a single axial ammonia ligand by an imidazole ligand, and substitution of both axial ammonia ligands. Initial geometries were fully optimized using the BLYP functional and the def2-SVP basis set. Solvent effects were included using integral equation formalism for a polarizable continuum model (IEPCM). ,

Following geometry optimization, 59Co NMR shielding constants were computed using the gauge-including atomic orbital (GIAO) method. NMR calculations employed a long-range corrected hybrid functional LC-ωPBE and Douglas–Kroll–Hess (DKH) Gaussian basis sets. ,

59Co NMR chemical shifts (δ59Co) were calculated using the following equation:

δCo59=σrefσcalc

where σref is the calculated shielding constant for [Co­(CN)6]3– as reference and σcalc is the calculated shielding constant for each Co­(III)­(acacen) complex in this study.

Functional Assay

Modified Thermo Scientific 1-Step Human Coupled IVT Kit – DNA (Catalog No. 88881) was employed. Samples were prepared according to the manufacturer’s protocol for GFP expression, followed by addition of test compounds.

Reagents were added to a sterile black wall, clear bottom 96 well plate in the following order using sterile pipet tips: HeLa Lysate (25 μL), Accessory Proteins (5 μL), Reaction Mix (10 μL), pCFE-GFP DNA (0.5 μg/μL, 4 μL), the test compound or control, and nuclease-free water to a final volume of 50 μL.

For Nsp1 inhibition studies, Nsp1 (from previously frozen stocks) was added to obtain a concentration of 1 μM for each reaction. Co­(III)­(acacen)­(NH3)2 + concentrations were either 1 or 5 μM in the final reaction. These samples were first incubated for 24 h at 4 °C, shaking at 80 rpm before being added to the assay. Co­(III)­(acacen)­(NH3)2 + does not inhibit GFP synthesis; this control with a single time point of the assay measured 6 h after incubating at 30 °C can be found in the data repository under associated content (Co­(acacen)_IVT.png).

A SpectraMax iD5Multi-Mode Microplate Reader was used in all experiments. Reaction solutions (50 uL) were placed in a black wall, clear bottom 96 well plate. Samples at 30 °C were shaken for 6 h with time points collected every 10 min. Sample was excitated at 488 nm and monitored at 512 nm.

Results and Discussion

Reaction of Co­(III)­(acacen)­(NH3)2 + with Nsp1-CT10

We first established the spectroscopic signature of Co­(III)­(acacen)­(NH3)2 + and characterized the kinetics of the reaction with Nsp1-CT10 by UV–vis absorption spectroscopy, before probing the coordination environment in detail by nuclear magnetic resonance (NMR) and computational methods. The UV–vis absorption spectrum of Co­(III)­(acacen)­(NH3)2 + displays a characteristic feature at approximately 340 nm, consistent with a low-spin Co­(III) complex comprised of equatorial N2O2 acacen coordination along with two N-donor axial ammines (Figure A). The reaction between Nsp1-CT10 and Co­(III)­(acacen)­(NH3)2 + was monitored for 24 h by absorption changes at 340 nm (Figure B). Prior literature suggests that this reaction occurs via multistep processes involving sequential aquation and ligand substitution.

2.

2

UV–vis spectra and kinetics of the reaction of Co­(III)­(acacen)­(NH3)2 + with Nsp1-CT10 in D2O. (A) Time evolution of the UV–vis absorption spectrum of Co­(acacen)­(NH3)2 + (100 μM) in aqueous solution with Nsp1-CT10 (100 μM). (B) Absorbance decay monitored at 340 nm over the full experimental time course (∼86,000 s), owing to formation of the Nsp1-CT10–Co­(acacen) complex.

1H NMR Spectra

The 1H NMR spectrum of Nsp1-CT10 in the aromatic region (δ 7–9 ppm) exhibits resonances characteristic of the His165 imidazole and the Trp161 indole groups (Figure ). A singlet at δ 8.5 ppm likely arises from C(2)-H of the His165 imidazole. The C(5)-H should be near δ 7.4 ppm but is obscured by resonance of the Trp161 indole protons. The C(2)-H chemical shift indicates a substantial imidazolium population. The 1H NMR spectrum of Nsp1-CT10 in the presence of Co­(III)­(acacen)­(NH3)2 + provides clear evidence for two complexes in a ratio of about 2.4:1. Resonances at δ 2.19 and 2.35 ppm are assigned to the two pairs of equivalent methyl groups on the acacen ligand in the major complex. Consequently, their integrated areas are defined as 6 protons and serve as the integration reference throughout. A smaller feature at δ 2.25 ppm integrates to 2.5H and is attributable to one pair of equivalent methyl groups in the minor complex. The C(2)-H resonance of the free peptide is all but eliminated in the presence of Co­(III)­(acacen)­(NH3)2 +, owing to His165 Co­(III) coordination (Figure ). Expansion of the 6.0–7.1 ppm region revealed four resonances at δ 6.06 (0.9H), 6.41 (0.3H), 6.98 (1.0H) and 7.3 (0.4H) ppm, none of which was present in the spectrum of free Co­(III)­(acacen)­(NH3)2 + or Nsp1-CT10, confirming that they arise from the His165 imidazole of Nsp1-CT10 upon coordination to the cobalt center. The resonance at δ 6.98 ppm integrates to approximately 1H relative to the 6H acacen methyl reference and likely arises from the Co­(III)-coordinated imidazole C(2)-H in the major complex. The C(5)-H resonance in Co­(III) imidazole complexes is generally 1 ppm upfield from the C(2)-H resonance, , thereby implicating the feature at δ 6.06 ppm as C(5)-H in the major Co­(III) complex. The two remaining resonances (δ 6.41 (0.3H), 7.3 (0.4H)) are attributable to C(5)-H and C(2)-H, respectively, in the minor complex. As Nsp1-CT10 contains only one histidine residue, bis-axial imidazole coordination would be expected to yield 2H at this chemical shift, however, the observation of 1H instead supports monoaxial histidine coordination as the predominant binding mode in solution, consistent with Co­(III)­(acacen)­(ImHis165)­(NH3)+ as the major species. The minor component could be Co­(III)­(acacen)­(ImHis165)­(OH2)+.

3.

3

1H NMR spectra of Nsp1-CT10 before (gold) and after (purple) incubation (24 h) with Co­(III)­(acacen)­(NH3)2 + in D2O. (A) Full presaturation 1H NMR spectrum (400 MHz, D2O) of Nsp1-CT10 in the presence of equimolar Co­(III)­(acacen)­(NH3)2 + (10 mM), with the D2O solvent peak omitted for clarity. (B) Expanded methyl region (1.95–2.50 ppm) showing two integrated resonances of 6H each (δ 2.323–2.360 ppm and δ 2.172–2.214 ppm), consistent with the two pairs of equivalent methyl groups of the acacen ligand. A smaller feature at δ 2.25 ppm is attributable to a one pair of equivalent acacen methyl protons on a minor population of the peptide coordinated Co­(III) complex. (C) Expanded imidazole and aromatic region (6.00–7.80 ppm) with highlighted resonances attributed to the histidine imidazole of Nsp1-CT10 upon coordination to Co­(III). Resonances integrating to 0.88H (δ 6.035–6.082 ppm), and 1H (δ 6.955–7.001 ppm) are assigned to Co­(III)-coordinated His165 imidazole C(5)-H and C(2)-H ring protons in the major complex. The corresponding resonances in the minor complex appear at δ 6.4 and 7.3 ppm. These features are not present in the spectrum of free Co­(III)­(acacen)­(NH3)2 +. All integration values are reported relative to the acacen methyl resonances in panel B (6H reference).

59Co NMR Spectra

Low-spin cobalt­(III) complexes are well suited for investigations by 59Co NMR spectroscopy. Cobalt-59 possesses a nuclear spin of I = 7/2 and a quadrupole moment of 0.4 × 10–24 cm2, thereby enabling NMR monitoring of changes in Co­(III) ligation. 59Co line widths are highly sensitive to electric field gradients (EFGs) at the cobalt center and, in turn, to the symmetry of inner-sphere coordination. A more asymmetric coordination produces a larger EFG, accelerating the quadrupolar relaxation and broadening the resonance. , Since 59Co chemical shifts span a very wide range, approximately 18,000 ppm, they provide exceptional sensitivity to changes in cobalt­(III) coordination. Importantly, line width changes upon ligand substitution or bimolecular binding reflect two distinct contributions: changes in quadrupolar coupling arising from altered coordination symmetry, and changes in the rotational correlation time (τc) of the complex, the latter increasing substantially upon binding to a large biomolecule such as a peptide or protein. ,, Both effects manifest as line width broadening and are therefore informative reporters of binding. Of relevance here is that 59Co NMR is a powerful tool for monitoring ligand substitution as well as other structural changes in cobalt­(III) Schiff base complexes.

Oxygen-donor ligation is associated with downfield 59Co-chemical shifts, owing in part to paramagnetic contributions from low-lying electronic excited states. In contrast, upfield 59Co resonance shifts are observed for complexes with N-donor coordination. These findings mean that 59Co chemical shifts offer a sensitive readout of axial ligand identity.

The 59Co NMR spectrum of Co­(acacen)­(NH3)2 + in D2O displays a well-defined resonance at 8472 ppm (Figure ), consistent with a Co­(III) center in a mixed N2O2 equatorial environment with axial nitrogen donors. The spectrum was acquired on a 400 MHz instrument, corresponding to an observation frequency of 94.9 MHz for 59Co. Lorentzian line shape fitting yielded a peak center of 8472 ppm and a fwhm of 30.85 ppm, corresponding to 2927.6 Hz at this field strength. Since 59Co (I = 7/2) is a quadrupolar nucleus, transverse relaxation occurs predominantly through the quadrupolar mechanism, and the line width directly reports on the spin–spin relaxation time T2 via T2 = 1/(πΔν), giving T2 = 0.109 ms. The relatively narrow line width reflects a small electric field gradient at the Cobalt­(III) nuclei, consistent with the well-defined and nearly symmetric coordination geometry imposed by the acacen ligand framework.

4.

4

59Co NMR spectrum of Co­(III)­(acacen)­(NH3)2 + in D2O. The prominent peak is at 8472 ppm.

Following overnight incubation of 1:1 Co­(III)­(acacen)­(NH3)2 +:Nsp1-CT10, the 59Co NMR peak assigned to Co­(III)­(acacen)­(NH3)2 + was replaced by a new peak at 8796 ppm (Figure ). Lorentzian line shape fitting yielded a peak fwhm of 20.69 ppm, corresponding to 1963.5 Hz at this field strength, consistent with T2 = 0.162 ms. Our 1H NMR measurements provide compelling evidence that under these conditions Co­(III)­(acacen)­(ImHis165)­(NH3)+ and possibly Co­(III)­(acacen)­(ImHis165)­(OH2)+ are formed. Calculated 59Co chemical shifts support this assignment of the 8796 peak to Co­(III)­(acacen)­(ImHis165)­(NH3)+ (vide infra).

5.

5

59Co NMR spectrum of Co­(III)­(acacen)­(NH3)2 + after 36-h incubation with 1 equiv of Nsp1-CT10 (the spectrum was collected in D2O; the prominent peak is at 8796 ppm).

The 33% reduction in 59Co NMR line width for Co­(III)­(acacen)­(ImHis165)­(NH3)+ relative to Co­(III)­(acacen)­(NH3)2 + is somewhat unexpected based on its lower symmetry and larger size, both of which can contribute to line broadening. Systematic investigations of 59Co NMR relaxation times in six-coordinate Co­(III) complexes suggest that line widths are dominated by the quadrupolar relaxation mechanism. The primary contributors to this relaxation are the asymmetry of the electric field gradient tensor (efg), the quadrupolar coupling constant, and the rotational correlation time of the complex. The study of 12 diverse Co­(III) complexes revealed that line widths and, hence, relaxation rates correlate well with quadrupolar coupling constants. The symmetry and size of the complexes were less reliable indicators of 59Co NMR line widths. The line narrowing in Co­(III)­(acacen)­(ImHis165)­(NH3)+, then, can be attributed to a modest reduction in quadrupolar coupling constant, owing to a decrease in the principal efg component.

Computational Analysis

An important question that arises from these observations is whether peptide coordination involves substitution of one or both axial ligands of Co­(III)­(acacen)­(NH3)2 +, and, if only one ligand is displaced, the identity of the remaining ligand. To elucidate the nature of this coordination change, QM calculations were performed for a series of plausible axial ligand combinations at the Co­(III) center, including water, ammonia, and imidazole ligands (Figure and Table ). The calculated 59Co NMR chemical shifts span a wide range (8500–12,500 ppm), highlighting the sensitivity of these chemical shifts to the nature of axial ligation.

6.

6

Computational structures of Co­(III)­(acacen) complexes with varying axial ligand combinations. All structures share the same equatorial N2O2 coordination environment defined by the acacen Schiff base ligand, with cobalt shown in pink, nitrogen in blue, oxygen in red, carbon in gray, and hydrogen in white. (A) Co­(acacen)­(H2O)2 +, with two axial water ligands. (B) Co­(acacen)­(H2O)­(NH3)+, with mixed axial water and ammonia coordination. (C) Co­(acacen)­(H2O)­(Im)+, with axial water and imidazole ligands. (D) Co­(acacen)­(NH3)2 +, with two axial ammonia ligands. (E) Co­(acacen)­(NH3)­(Im)+, with mixed axial ammonia and imidazole coordination. (F) Co­(acacen)­(Im)2 +, with two axial imidazole ligands. The series illustrates the progressive substitution of axial ligands from oxygen donors (H2O) to nitrogen donors (NH3 and imidazole), which is relevant to the coordination chemistry of Co­(III)­(acacen) in the presence of histidine-containing peptides such as Nsp1-CT10.

1. Computationally Predicted 59Co NMR [Co­(III)­(acacen)] Complex Chemical Shifts with Variations in Axial Ligation.

Co(III)(acacen) complex axial ligands predicted NMR chemical shift (ppm)
A H2O–H2O 12,493
B H2O-NH3 9772
C H2O-imidazole 10,251
D NH3–NH3 8505
E NH3–imidazole 8752
F imidazole–imidazole 9240

The calculated chemical shift for NH3–NH3 axial ligation is 8505 ppm, in excellent agreement with the experimentally observed 8477 ppm for Co­(III)­(acacen)­(NH3)2 +. This agreement supports the reliability of the computational approach in capturing the electronic environment at the Co­(III) center, thereby providing a validated reference point for assigning ligand substitutions.

Of interest, the calculated 59Co chemical shift of 8752 ppm for NH3–imidazole axial ligation (Figure E) is near the experimentally observed 8877 ppm peak for the Co­(III) derivative of Nsp1-CT10. In contrast, models involving substitution of both axial ammines (imidazole–imidazole, 9240 ppm) or coordination by water ligands (H2O–NH3, H2O–imidazole, and H2O–H2O) have calculated chemical shifts that deviate substantially from the experimental NMR peak position. Based on these data, we conclude that reaction of Co­(III)­(acacen)­(NH3)2 + with Nsp1-CT10 involves displacement of an axial ammine by the His165 imidazole.

Fragmentation and Mass Spectrometry Analysis

Axial ligand substitutions in Co­(III)­(acacen)­(NH3)2 + will not be restricted to His165 in full-length Nsp1, as the protein contains seven histidine residues: His13, His45, His81, His83, His110, His134, and His165 (Figure ). Of these, His13, His45, His81, His83, and His110 reside within the structured N-terminal domain (residues 1–127), His134 is in the linker region, and His165 is in the disordered C-terminal domain. These assignments are based on the NMR solution structure of Nsp1 (PDB ID: 8AOU). In this structure His45, His81, His83, His134, and His165 are surface exposed and therefore accessible to metal complexes, whereas His13 and His110 are buried within the globular core of the N-terminal domain. We expect Co­(III)­(acacen)­(NH3)2 + to bind to the accessible histidine residues in the protein.

7.

7

NMR solution structure of full-length Nsp1, with the 7 histidine residues highlighted. PDB ID: 8AOU.

Recombinantly expressed Nsp1 was incubated with one equivalent of Co­(III)­(acacen)­(NH3)2 + prior to proteolytic fragmentation. Trypsin digestion yielded peptide fragments that in most cases contained a single histidine residue (the exception being the closely spaced His81 and His83 residues, which were not found in separate fragments). The resulting peptide mixtures were analyzed by mass spectrometry to determine which fragments contained Co­(III) complexes. Three sites of Co­(III) coordination were identified: His13, the His81/His83 region, and His165.

Functional Assay

An in vitro translation assay was employed in which protein synthesis was monitored by production of green fluorescent protein (GFP). In this assay, recombinantly expressed full-length Nsp1 produced in E. coli robustly suppresses translation, resulting in decreased GFP expression. Since His165 in full-length Nsp1 binds to Co­(III)­(acacen)­(NH3)2 +, we asked whether Co­(III) coordination might be sufficient to disrupt Nsp1’s interaction with the 40S ribosome and thereby restore GFP production.

However, we found that treatment of Nsp1 with Co­(III)­(acacen)­(NH3)2 + did not restore GFP expression (Figure ). Although full-length Nsp1 inhibited translation relative to the control, the incubation with either 1 or 5 equiv of Co­(III)­(acacen)­(NH3)2 + (relative to Nsp1 concentration) failed to rescue GFP production.

8.

8

Our in vitro translation assay confirmed GFP is not produced upon incubation of full-length Nsp1 with Co­(III)­(acacen)­(NH3)2 +.

Concluding Remarks

Co­(III)­(acacen)­(NH3)2 + reacts with full-length Nsp1, and mass spectrometric analysis of protein fragments revealed multiple Co­(III) coordination sites: His13, the His 81/His83 region, and His165. Functional assays, however, demonstrate that targeting Nsp1 with Co­(III)­(acacen)­(NH3)2 + does not restore protein translation. In sharp contrast, several studies have shown that a Lys164Ala/His165Ala double mutation restores protein translation, ,, thereby indicating a critical role for both residues in Nsp1 binding to the 40S ribosome. Of importance is work on Nsp1 single-site mutants strongly indicating Lys164 is the key residue for inhibition of host protein synthesis and that mutation of His165 alone had a substantially smaller impact. The importance of Lys164 suggests that Lys164:His165 bidentate metal-binding would inhibit Nsp1 interactions with the 40S ribosome. It should be noted that Co­(III)­(acacen)­(NH3)2 + acts as a general histidine modifier rather than a targeted inhibitor of His165, as evidenced by the coordination to multiple surface exposed histidines in full length Nsp1. Future efforts directed toward bidentate coordination to a Lys164:His165 motif, or toward Co­(III) complexes with improved selectivity for this functionally critical site, may provide a more effective strategy for disrupting Nsp1-mediated translational suppression.

Supplementary Material

ic6c01698_si_001.pdf (758.6KB, pdf)

Acknowledgments

We thank Dr. David Vandervelde (Caltech CCE NMR Facility) for valuable assistance with this research; Dr. Yuling Sheng for assistance with protein expression; and Yeongjun Yu at Pohang University of Science and Technology for assistance with syntheses. Mass spectrometry was performed at the Caltech Proteome Exploration Laboratory and the authors thank Dr. Baiyi Quan for technical assistance.

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.inorgchem.6c01698.

  • UV–vis kinetics data, 1H NMR, and 59Co NMR spectra (PDF)

The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.

Research was supported in part by the National Heart Lung and Blood Institute of the NIH under award numbers R01HL155532 and R35HL150807 (subcontracts to W.A.G.). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Additional support was provided by the Beckman Institute at Caltech and the Arnold and Mabel Beckman Foundation.

TOC graphic was prepared using components from Alphafold 3 and BioRender.com.

The authors declare no competing financial interest.

References

  1. Finkel Y., Gluck A., Nachshon A., Winkler R., Fisher T., Rozman B., Mizrahi O., Lubelsky Y., Zuckerman B., Slobodin B., Yahalom-Ronen Y., Tamir H., Ulitsky I., Israely T., Paran N., Schwartz M., Stern-Ginossar N.. SARS-CoV-2 Uses a Multipronged Strategy to Impede Host Protein Synthesis. Nature. 2021;594(7862):240–245. doi: 10.1038/s41586-021-03610-3. [DOI] [PubMed] [Google Scholar]
  2. Lapointe C. P., Grosely R., Johnson A. G., Wang J., Fernández I. S., Puglisi J. D.. Dynamic Competition between SARS-CoV-2 NSP1 and mRNA on the Human Ribosome Inhibits Translation Initiation. Proc. Natl. Acad. Sci. U.S.A. 2021;118(6):e2017715118. doi: 10.1073/pnas.2017715118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Schubert K., Karousis E. D., Jomaa A., Scaiola A., Echeverria B., Gurzeler L.-A., Leibundgut M., Thiel V., Mühlemann O., Ban N.. SARS-CoV-2 Nsp1 Binds the Ribosomal mRNA Channel to Inhibit Translation. Nat. Struct Mol. Biol. 2020;27(10):959–966. doi: 10.1038/s41594-020-0511-8. [DOI] [PubMed] [Google Scholar]
  4. Finkel Y., Mizrahi O., Nachshon A., Weingarten-Gabbay S., Morgenstern D., Yahalom-Ronen Y., Tamir H., Achdout H., Stein D., Israeli O., Beth-Din A., Melamed S., Weiss S., Israely T., Paran N., Schwartz M., Stern-Ginossar N.. The Coding Capacity of SARS-CoV-2. Nature. 2021;589(7840):125–130. doi: 10.1038/s41586-020-2739-1. [DOI] [PubMed] [Google Scholar]
  5. Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T., Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J., Straub J. H., Stürzel C. M., Fröhlich T., Berninghausen O., Becker T., Kirchhoff F., Sparrer K. M. J., Beckmann R.. Structural Basis for Translational Shutdown and Immune Evasion by the Nsp1 Protein of SARS-CoV-2. Science. 2020;369(6508):1249–1255. doi: 10.1126/science.abc8665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Yuan S., Peng L., Park J. J., Hu Y., Devarkar S. C., Dong M. B., Shen Q., Wu S., Chen S., Lomakin I. B., Xiong Y.. Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA. Mol. Cell. 2020;80(6):1055–1066. doi: 10.1016/j.molcel.2020.10.034. [DOI] [PMC free article] [PubMed] [Google Scholar]; e6
  7. Zhang K., Miorin L., Makio T., Dehghan I., Gao S., Xie Y., Zhong H., Esparza M., Kehrer T., Kumar A., Hobman T. C., Ptak C., Gao B., Minna J. D., Chen Z., García-Sastre A., Ren Y., Wozniak R. W., Fontoura B. M. A.. Nsp1 Protein of SARS-CoV-2 Disrupts the mRNA Export Machinery to Inhibit Host Gene Expression. Sci. Adv. 2021;7(6):eabe7386. doi: 10.1126/sciadv.abe7386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Narayanan K., Huang C., Lokugamage K., Kamitani W., Ikegami T., Tseng C.-T. K., Makino S.. Severe Acute Respiratory Syndrome Coronavirus Nsp1 Suppresses Host Gene Expression, Including That of Type I Interferon, in Infected Cells. J. Virol. 2008;82(9):4471–4479. doi: 10.1128/JVI.02472-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Shen Z., Zhang G., Yang Y., Li M., Yang S., Peng G.. Lysine 164 Is Critical for SARS-CoV-2 Nsp1 Inhibition of Host Gene Expression. J. Gen. Virol. 2021;102(1):jgv001513. doi: 10.1099/jgv.0.001513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Afsar M., Narayan R., Akhtar M. N., Das D., Rahil H., Nagaraj S. K., Eswarappa S. M., Tripathi S., Hussain T.. Drug Targeting Nsp1-Ribosomal Complex Shows Antiviral Activity against SARS-CoV-2. eLife. 2022;11:e74877. doi: 10.7554/eLife.74877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Peyrone M.. Ueber Die Einwirkung Des Ammoniaks Auf Platinchlorür. Justus Liebigs Ann. Chem. 1844;51(1):1–29. doi: 10.1002/jlac.18440510102. [DOI] [Google Scholar]
  12. Rosenberg B., Van Camp L., Krigas T.. Inhibition of Cell Division in Escherichia Coli by Electrolysis Products from a Platinum Electrode. Nature. 1965;205(4972):698–699. doi: 10.1038/205698a0. [DOI] [PubMed] [Google Scholar]
  13. Kenny R. G., Marmion C. J.. Toward Multi-Targeted Platinum and Ruthenium DrugsA New Paradigm in Cancer Drug Treatment Regimens? Chem. Rev. 2019;119(2):1058–1137. doi: 10.1021/acs.chemrev.8b00271. [DOI] [PubMed] [Google Scholar]
  14. Johnstone T. C., Suntharalingam K., Lippard S. J.. The Next Generation of Platinum Drugs: Targeted Pt­(II) Agents, Nanoparticle Delivery, and Pt­(IV) Prodrugs. Chem. Rev. 2016;116(5):3436–3486. doi: 10.1021/acs.chemrev.5b00597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ghosh S.. Cisplatin: The First Metal Based Anticancer Drug. Bioorg. Chem. 2019;88:102925. doi: 10.1016/j.bioorg.2019.102925. [DOI] [PubMed] [Google Scholar]
  16. Boros E., Dyson P. J., Gasser G.. Classification of Metal-Based Drugs According to Their Mechanisms of Action. Chem. 2020;6(1):41–60. doi: 10.1016/j.chempr.2019.10.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Morales M., Yang M. Y., Goddard W. A., Gray H. B., Winkler J. R.. Copper­(II) Coordination to the Intrinsically Disordered Region of SARS-CoV-2 Nsp1. Proc. Natl. Acad. Sci. U.S.A. 2024;121(20):e2402653121. doi: 10.1073/pnas.2402653121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Morales M., Ravanfar R., Oyala P. H., Gray H. B., Winkler J. R.. Copper­(II) Binding to the Intrinsically Disordered C-Terminal Peptide of SARS-CoV-2 Virulence Factor Nsp1. Inorg. Chem. 2022;61(24):8992–8996. doi: 10.1021/acs.inorgchem.2c01329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Böttcher A., Takeuchi T., Hardcastle K. I., Meade T. J., Gray H. B., Cwikel D., Kapon M., Dori Z.. Spectroscopy and Electrochemistry of Cobalt­(III) Schiff Base Complexes. Inorg. Chem. 1997;36(12):2498–2504. doi: 10.1021/ic961146v. [DOI] [Google Scholar]
  20. Harney A. S., Sole L. B., Meade T. J.. Kinetics and Thermodynamics of Irreversible Inhibition of Matrix Metalloproteinase 2 by a Co­(III) Schiff Base Complex. J. Biol. Inorg. Chem. 2012;17(6):853–860. doi: 10.1007/s00775-012-0902-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Blum O., Haiek A., Cwikel D., Dori Z., Meade T. J., Gray H. B.. Isolation of a Myoglobin Molten Globule by Selective Cobalt­(III)-Induced Unfolding. Proc. Natl. Acad. Sci. U.S.A. 1998;95(12):6659–6662. doi: 10.1073/pnas.95.12.6659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Takeuchi T., Böttcher A., Quezada C. M., Simon M. I., Meade T. J., Gray H. B.. Selective Inhibition of Human α-Thrombin by Cobalt­(III) Schiff Base Complexes. J. Am. Chem. Soc. 1998;120(33):8555–8556. doi: 10.1021/ja981191x. [DOI] [Google Scholar]
  23. Böttcher A., Gray H. B., Meade T. J., Simon M. I., Takeuchi T.. Irreversible Enzymatic Inhibition by Cobalt Chelate Complexes. J. Inorg. Biochem. 1995;59(2–3):221. doi: 10.1016/0162-0134(95)97327-M. [DOI] [Google Scholar]
  24. Üngör Ö., Ozvat T. M., Ni Z., Zadrozny J. M.. Record Chemical-Shift Temperature Sensitivity in a Series of Trinuclear Cobalt Complexes. J. Am. Chem. Soc. 2022;144(20):9132–9137. doi: 10.1021/jacs.2c03115. [DOI] [PubMed] [Google Scholar]
  25. Ozvat T. M., Johnson S. H., Rappé A. K., Zadrozny J. M.. Ligand Control of 59Co Nuclear Spin Relaxation Thermometry. Magnetochemistry. 2020;6(4):58. doi: 10.3390/magnetochemistry6040058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Üngör Ö., Sanchez S., Ozvat T. M., Zadrozny J. M.. Asymmetry-Enhanced59 Co NMR Thermometry in Co­(iii) Complexes. Inorg. Chem. Front. 2023;10(23):7064–7072. doi: 10.1039/D3QI01641B. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Asaro F., Liguori L., Pellizer G.. Exceptional Deshielding of59Co Caused by Deuteration of the Hydrogen Bonds in Cobaloximes. Angew. Chem. 2000;112(11):2008–2010. doi: 10.1002/1521-3757(20000602)112::11<2008:AID-ANGE2008>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  28. Frisch, M. J. ; Trucks, G. W. ; Schlegel, H. B. ; Scuseria, G. E. ; Robb, M. A. ; Cheeseman, J. R. ; Scalmani, G. ; Barone, V. ; Petersson, G. A. ; Nakatsuji, H. ; Li, X. ; Caricato, M. ; Marenich, A. V. ; Bloino, J. ; Janesko, B. G. ; Gomperts, R. ; Mennucci, B. ; Hratchian, H. P. ; Ortiz, J. V. ; Izmaylov, A. F. ; Sonnenberg, J. L. ; Williams-Young, D. ; Ding, F. ; Lipparini, F. ; Egidi, F. ; Goings, J. ; Peng, B. ; Petrone, A. ; Henderson, T. ; Ranasinghe, D. ; Zakrzewski, V. G. ; Gao, J. ; Rega, N. ; Zheng, G. ; Liang, W. ; Hada, M. ; Ehara, M. ; Toyota, K. ; Fukuda, R. ; Hasegawa, J. ; Ishida, M. ; Nakajima, T. ; Honda, Y. ; Kitao, O. ; Nakai, H. ; Vreven, T. ; Throssell, K. ; Montgomery, J. A., Jr. ; Peralta, J. E. ; Ogliaro, F. ; Bearpark, M. J. ; Heyd, J. J. ; Brothers, E. N. ; Kudin, K. N. ; Staroverov, V. N. ; Keith, T. A. ; Kobayashi, R. ; Normand, J. ; Raghavachari, K. ; Rendell, A. P. ; Burant, J. C. ; Iyengar, S. S. ; Tomasi, J. ; Cossi, M. ; Millam, J. M. ; Klene, M. ; Adamo, C. ; Cammi, R. ; Ochterski, J. W. ; Martin, R. L. ; Morokuma, K. ; Farkas, O. ; Foresman, J. B. ; Fox, D. J. . Gaussian 16, 2016. [Google Scholar]
  29. Scalmani G., Frisch M. J.. Continuous Surface Charge Polarizable Continuum Models of Solvation. I. General Formalism. J. Chem. Phys. 2010;132(11):114110. doi: 10.1063/1.3359469. [DOI] [PubMed] [Google Scholar]
  30. Wolinski K., Hinton J. F., Pulay P.. Efficient Implementation of the Gauge-Independent Atomic Orbital Method for NMR Chemical Shift Calculations. J. Am. Chem. Soc. 1990;112(23):8251–8260. doi: 10.1021/ja00179a005. [DOI] [Google Scholar]
  31. Iikura H., Tsuneda T., Yanai T., Hirao K.. A Long-Range Correction Scheme for Generalized-Gradient-Approximation Exchange Functionals. J. Chem. Phys. 2001;115(8):3540–3544. doi: 10.1063/1.1383587. [DOI] [Google Scholar]
  32. Gomes M. G. R., De Souza A. L. F., Dos Santos H. F., De Almeida W. B., Paschoal D. F. S.. Assessment of a Computational Protocol for Predicting Co-59 NMR Chemical Shift. Magnetochemistry. 2023;9(7):172. doi: 10.3390/magnetochemistry9070172. [DOI] [Google Scholar]
  33. Manus L. M., Holbrook R. J., Atesin T. A., Heffern M. C., Harney A. S., Eckermann A. L., Meade T. J.. Axial Ligand Exchange of N -Heterocyclic Cobalt­(III) Schiff Base Complexes: Molecular Structure and NMR Solution Dynamics. Inorg. Chem. 2013;52(2):1069–1076. doi: 10.1021/ic302379j. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Markley J. L.. Observation of Histidine Residues in Proteins by Nuclear Magnetic Resonance Spectroscopy. Acc. Chem. Res. 1975;8(2):70–80. doi: 10.1021/ar50086a004. [DOI] [Google Scholar]
  35. Gillespie R. J., Granger P., Morgan K. R., Schrobilgen G. J.. Mercury-199 NMR Study of the Mercury Cations (Hg2+, Hg22+, Hg32+, and Hg42+): The First Example of Mercury-Mercury Spin-Spin Coupling. Inorg. Chem. 1984;23(7):887–891. doi: 10.1021/ic00175a019. [DOI] [Google Scholar]
  36. Hackbusch W., Rupp H. H., Wieghardt K.. Cobalt-59 Nuclear Magnetic Resonance Study of μ-Carboxylato-Di-μ-Hydroxo-Bis­[Triamminecobalt­(III)] Complexes. J. Chem. Soc., Dalton Trans. 1975;(No. 22):2364. doi: 10.1039/dt9750002364. [DOI] [Google Scholar]
  37. Yamasaki A.. Cobalt-59 Nuclear Magnetic Resonance Spectroscopy in Coordination Chemistry. J. Coord. Chem. 1991;24(3):211–260. doi: 10.1080/00958979109407886. [DOI] [Google Scholar]
  38. NMR and the Periodic Table, Harris, R. K. ; Mann, B. E. , Eds.; Acad. Press: London, 1978. [Google Scholar]
  39. Griffith J. S., Orgel L. E.. Ligand-Field Theory. Q. Rev., Chem. Soc. 1957;11(4):381. doi: 10.1039/qr9571100381. [DOI] [Google Scholar]
  40. Au-Yeung S. C. F., Eaton D. R.. The Solvent and Field Dependence of 59Co NMR Linewidths. J. Magn. Reson. (1969) 1983;52(3):366–373. doi: 10.1016/0022-2364(83)90163-4. [DOI] [Google Scholar]
  41. Mason, J. Multinuclear NMR; Plenum press: New York London, 1989. [Google Scholar]
  42. Kirby C. W., Puranda C. M., Power W. P.. Cobalt-59 Nuclear Magnetic Relaxation Studies of Aqueous Octahedral Cobalt­(III) Complexes. J. Phys. Chem. A. 1996;100(35):14618–14624. doi: 10.1021/jp9614254. [DOI] [Google Scholar]
  43. Levitt, M. H. Spin Dynamics: Basics of Nuclear Magnetic Resonance, 2. ed., repr.; Wiley: Chichester, 2011. [Google Scholar]
  44. Wang Y., Kirkpatrick J., Lage S. Z., Carlomagno T.. Structural Insights into the Activity Regulation of Full-Length Non-Structural Protein 1 from SARS-CoV-2. Structure. 2023;31(2):128–137. doi: 10.1016/j.str.2022.12.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Clark L. K., Green T. J., Petit C. M.. Structure of Nonstructural Protein 1 from SARS-CoV-2. J. Virol. 2021;95(4):e02019-20. doi: 10.1128/JVI.02019-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Abramson J., Adler J., Dunger J., Evans R., Green T., Pritzel A., Ronneberger O., Willmore L., Ballard A. J., Bambrick J., Bodenstein S. W., Evans D. A., Hung C.-C., O’Neill M., Reiman D., Tunyasuvunakool K., Wu Z., Žemgulyte A., Arvaniti E., Beattie C., Bertolli O., Bridgland A., Cherepanov A., Congreve M., Cowen-Rivers A. I., Cowie A., Figurnov M., Fuchs F. B., Gladman H., Jain R., Khan Y. A., Low C. M. R., Perlin K., Potapenko A., Savy P., Singh S., Stecula A., Thillaisundaram A., Tong C., Yakneen S., Zhong E. D., Zielinski M., Žídek A., Bapst V., Kohli P., Jaderberg M., Hassabis D., Jumper J. M.. Accurate Structure Prediction of Biomolecular Interactions with AlphaFold 3. Nature. 2024;630(8016):493–500. doi: 10.1038/s41586-024-07487-w. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ic6c01698_si_001.pdf (758.6KB, pdf)

Articles from Inorganic Chemistry are provided here courtesy of American Chemical Society

RESOURCES